Morepen Enters U.S. Prescription Generics Market with the Launch of its Desloratadine Tablets, Complementing Broader API, R&D and CDMO Growth Strategy
Morepen Laboratories Limited announced the launch of its first prescription (Rx) generic product, Desloratadine Tablets USP, 5 mg, in 100-count
Read More